PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 17360008-0 2007 Antihyperalgesic efficacy of lacosamide in a rat model for muscle pain induced by TNF. Lacosamide 29-39 tumor necrosis factor Rattus norvegicus 82-85 30118739-6 2018 Treatment with PGB or LCM restored the sciatic nerve content of the depleted total antioxidant capacity (TAC) and nerve growth factor (NGF), and lessened the elevated contents of nuclear factor kappa B p65 (NF-kB p65), tumor necrosis factor-alpha (TNF-alpha), and active caspase-3. Lacosamide 22-25 tumor necrosis factor Rattus norvegicus 219-246 30118739-6 2018 Treatment with PGB or LCM restored the sciatic nerve content of the depleted total antioxidant capacity (TAC) and nerve growth factor (NGF), and lessened the elevated contents of nuclear factor kappa B p65 (NF-kB p65), tumor necrosis factor-alpha (TNF-alpha), and active caspase-3. Lacosamide 22-25 tumor necrosis factor Rattus norvegicus 248-257 25916937-2 2015 The aim of this study is to investigate the potential anti-inflammatory and lipid-peroxidation inhibiting activities of lacosamide by measuring tumour necrotizing factor-alpha (TNF-alpha), C-reactive protein (CRP), malondialdehyde (MDA) and white blood cells (WBC) using electroneuromyography (ENMG) in rats with sepsis-induced critical illness neuropathy (SICIN). Lacosamide 120-130 tumor necrosis factor Rattus norvegicus 177-186 25916937-7 2015 When CLP, CLP+lacosamide 20 mg/kg and CLP+lacosamide 40 mg/kg groups were compared, plasma levels of TNF-alpha and MDA were significantly higher in the untreated CLP group (F = 12.74, P < 0.0001), (F = 19.43, P < 0.05). Lacosamide 42-52 tumor necrosis factor Rattus norvegicus 101-110 33925082-7 2021 Lacosamide treatment after SE mitigated the increased levels of IL-1beta and TNF-alpha in the hippocampus and exerted strong neuroprotection both in the dorsal and ventral hippocampus, basolateral amygdala, and partially in the piriform cortex. Lacosamide 0-10 tumor necrosis factor Rattus norvegicus 77-86